-transparent.png){kind=logo}
Forty-six patients with recurrent disseminated ovarian carcinoma were treated with a combination of cis-dichlorodiammine platinum II (DDP) 50 mg/m2 and adriamycin 50 mg/m2 given intravenously every 3 weeks. All patients had failed prior chemotherapy. The combination of adriamycin and DDP produced objective responses in 14 of 46 patients. Severe side effects were frequent, but no patient died as a result of treatment. Disease in 4 of 7 complete responders is currently in remission up to 4 years.
Related Publications
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
June 1979,
The Medical journal of Australia,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
April 1978,
Clinical pharmacology and therapeutics,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
January 1982,
Therapeutic drug monitoring,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
October 1994,
The Journal of biological chemistry,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
October 1989,
Artificial organs,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
October 1980,
Cancer,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
January 1986,
Gynecologic oncology,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
January 1980,
Toxicology,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
September 1979,
Mutation research,
R C Wallach, and
C Cohen, and
H Bruckner, and
B Kabakow, and
G Deppe, and
L Ratner
January 1983,
American journal of otolaryngology,
